美国FDA批准治疗肺动脉高压（PAH）的新型药物。 U.S. FDA approves new drug treatment for pulmonary arterial hypertension (PAH).
美国 FDA 批准了一种治疗肺动脉高压（PAH）的新药，这是一种罕见且通常致命的肺部疾病。 The U.S. FDA has approved a new drug treatment for pulmonary arterial hypertension (PAH), a rare and often fatal lung disease. 这种创新药物在波士顿进行了测试，显著改善了肺动脉高压患者迈克·贝内特的生活，他已经与这种疾病斗争了二十多年。 Tested in Boston, the innovative drug has significantly improved the life of PAH patient Mike Bennett, who has been battling the condition for over two decades. FDA 对此种治疗方法的批准为 PAH 患者控制症状和改善生活质量带来了希望。 The FDA's approval of this treatment offers hope for PAH patients in managing their symptoms and improving their quality of life.